Document is current
Any future updates will be listed below
-
Authors
Stein, Murray B. https://orcid.org/0000-0001-9564-2871
Levey, Daniel F. https://orcid.org/0000-0001-8431-9569
Cheng, Zhongshan
Wendt, Frank R.
Harrington, Kelly
Pathak, Gita A.
Cho, Kelly
Quaden, Rachel
Radhakrishnan, Krishnan
Girgenti, Matthew J. https://orcid.org/0000-0003-1647-326X
Ho, Yuk-Lam Anne https://orcid.org/0000-0003-3305-3830
Posner, Daniel https://orcid.org/0000-0002-3056-6924
Aslan, Mihaela
Duman, Ronald S.
Zhao, Hongyu https://orcid.org/0000-0003-1195-9607
,
Stein, Murray B.
Levey, Daniel F.
Cheng, Zhongshan
Wendt, Frank R.
Pathak, Gita A.
Radhakrishnan, Krishnan
Aslan, Mihaela
Zhao, Hongyu
Polimanti, Renato
Concato, John
Gelernter, Joel
,
Stein, Murray B.
Levey, Daniel F.
Cheng, Zhongshan
Wendt, Frank R.
Harrington, Kelly
Pathak, Gita A.
Cho, Kelly
Quaden, Rachel
Ho, Yuk-Lam Anne
Posner, Daniel
Polimanti, Renato
Concato, John
Gelernter, Joel
Polimanti, Renato https://orcid.org/0000-0003-0745-6046
Concato, John
Gelernter, Joel https://orcid.org/0000-0002-4067-1859
- License Information
-
More Information
Article History
Received: 4 March 2020
Accepted: 15 December 2020
First Online: 28 January 2021
Competing interests
: M.B.S. has in the past 3 years been a consultant for Actelion, Acadia Pharmaceuticals, Aptinyx, Bionomics, BioXcel Therapeutics, Clexio, EmpowerPharm, Epivario, GW Pharmaceuticals, Janssen, Jazz Pharmaceuticals, Roche/Genentech and Oxeia Biopharmaceuticals. M.B.S. has stock options in Oxeia Biopharmaceuticals and Epivario. J.G. is named as coinventor on PCT patent application no. 15/878,640, entitled ‘Genotype-guided dosing of opioid agonists’, filed 24 January 2018. None of the other authors declare any competing interests.
